# STEALTH BIOTHERAPEUTICS CORP (MITO)

> Institutional ownership reported to the SEC as of Q3 2022, from Form 13F filings. Source: https://holderbook.com/stocks/MITO/

- Reporting holders: 11
- Reported value: $277.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Ikarian Capital, LLC](https://holderbook.com/funds/1778253-ikarian-capital-llc/) | $134.0K | 435,516 | 0.0% | 12 |
| [BROWN BROTHERS HARRIMAN & CO](https://holderbook.com/funds/14661-brown-brothers-harriman-co/) | $54.0K | 174,999 | 0.0% | 12 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $30.0K | 96,944 | 0.0% | 11 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $15.0K | 48,791 | 0.0% | 5 |
| [BOOTHBAY FUND MANAGEMENT, LLC](https://holderbook.com/funds/1549230-boothbay-fund-management-llc/) | $14.0K | 43,790 | 0.0% | 7 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $10.0K | 30,991 | 0.0% | 2 |
| [ENVESTNET ASSET MANAGEMENT INC](https://holderbook.com/funds/1407543-envestnet-asset-management-inc/) | $7.0K | 23,248 | 0.0% | 4 |
| [CAPTRUST FINANCIAL ADVISORS](https://holderbook.com/funds/1512024-captrust-financial-advisors/) | $5.0K | 15,000 | 0.0% | 2 |
| [TWO SIGMA ADVISERS, LP](https://holderbook.com/funds/1478735-two-sigma-advisers-lp/) | $4.0K | 13,700 | 0.0% | 6 |
| [ADVISOR GROUP HOLDINGS, INC.](https://holderbook.com/funds/1677044-advisor-group-holdings-inc/) | $3.0K | 10,124 | 0.0% | 9 |
| [AlphaMark Advisors, LLC](https://holderbook.com/funds/1348183-alphamark-advisors-llc/) | $1.0K | 2,306 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2022 | 11 | $277.0K |
| Q2 2022 | 19 | $334.0K |
| Q1 2022 | 13 | $638.0K |
| Q4 2021 | 13 | $752.0K |
| Q3 2021 | 13 | $1.2M |
| Q2 2021 | 12 | $1.5M |
| Q1 2021 | 13 | $3.9M |
| Q4 2020 | 13 | $1.5M |
| Q3 2020 | 10 | $835.0K |
| Q2 2020 | 9 | $1.5M |
| Q1 2020 | 10 | $947.0K |
| Q4 2019 | 4 | $752.0K |